Frequently Asked Questions about Amneal Pharmaceuticals, Inc. (AMRX)

Name: Amneal Pharmaceuticals, Inc. (AMRX) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Amneal Pharmaceuticals, Inc. (AMRX) do?

Accepted Answer

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Gen...

Question 2

Is Amneal Pharmaceuticals, Inc. (AMRX) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of AMRX reveals an Altman Z-Score of 1.93 and a Piotroski F-Score of 7/9. These metrics, combined with its 5-year revenue trend ($3.02B most recent), help investors decide if AMRX fits their risk profile.

Question 3

What is the current P/E ratio for AMRX?

Accepted Answer

As of the latest trading session, Amneal Pharmaceuticals, Inc. (AMRX) has a trailing P/E ratio of 53.71.

Question 4

Who is the CEO of Amneal Pharmaceuticals, Inc.?

Accepted Answer

The current Chief Executive Officer of Amneal Pharmaceuticals, Inc. is Chirag K. Patel.

Question 5

What was AMRX's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Amneal Pharmaceuticals, Inc. reported annual revenues of $3.02B (2025), $2.79B (2024), $2.39B (2023), $2.21B (2022), $2.09B (2021) respectively.

Question 6

Does AMRX pay a dividend?

Accepted Answer

Amneal Pharmaceuticals, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does AMRX have?

Accepted Answer

In its latest reporting period, Amneal Pharmaceuticals, Inc. generated $0.27B in Free Cash Flow against a total debt load of $2.74B.

Question 8

What is the Price-to-Book (P/B) ratio of Amneal Pharmaceuticals, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Amneal Pharmaceuticals, Inc. (AMRX) is currently -54.67.

Question 9

What is the Price-to-Sales (P/S) ratio of AMRX?

Accepted Answer

Based on trailing twelve-month data, Amneal Pharmaceuticals, Inc. (AMRX) trades at a Price-to-Sales (P/S) ratio of 1.29.

Question 10

What is Amneal Pharmaceuticals, Inc.'s Return on Equity (ROE)?

Accepted Answer

Amneal Pharmaceuticals, Inc. (AMRX) has a Return on Equity (ROE) of -67.91%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	340M	32M	-70.1M	269.9M	238M
2024-12	295.1M	27.8M	-75M	220.1M	192.3M
2023-12	345.6M	26.8M	-69.2M	276.4M	249.6M
2022-12	65.1M	31.8M	-90.6M	-25.5M	-57.3M
2021-12	241.8M	0	-47.7M	194.1M	194.1M

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	340M	32M	-70.1M	269.9M	238M
2024-12	295.1M	27.8M	-75M	220.1M	192.3M
2023-12	345.6M	26.8M	-69.2M	276.4M	249.6M
2022-12	65.1M	31.8M	-90.6M	-25.5M	-57.3M
2021-12	241.8M	0	-47.7M	194.1M	194.1M